ストックスクリーナーアプリを入手
0.468
41.86%
0.1381
前日終値:
$0.3299
開ける：
$0.324
24時間の取引高:
96.12M
Relative Volume:
30.63
時価総額：
$1.64M
収益：
$142.00K
当期純損益:
$-1.23M
株価収益率:
1.0049
EPS:
0.4657
ネットキャッシュフロー:
$-10.62M
1週間 パフォーマンス:
+35.81%
1か月 パフォーマンス:
-48.22%
6か月 パフォーマンス:
-79.47%
1年 パフォーマンス:
-73.21%
1日の値動き範囲:
$0.3086
$0.5833
1週間の範囲:
$0.308
$0.5833
52週間の値動き範囲:
$0.308
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Compare VIVS vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
0.468 | 1.36M | 142.00K | -1.23M | -10.62M | 0.4657 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-12-13 | 開始されました | H.C. Wainwright | Buy |
| 2017-11-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | 開始されました | Raymond James | Outperform |
| 2015-08-11 | ダウングレード | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | 開始されました | Jefferies | Buy |
| 2015-06-29 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Vivosim Labs Inc (VIVS) 最新ニュース
VivoSim Labs, Inc. Revenue Breakdown – NASDAQ:VIVS - TradingView
VIVS|VivoSim Labs Ord Shs|Price:0.413|Chg%:-0.037 - TradingKey
VivoSim Labs Addresses Nasdaq Listing Compliance Concerns - TipRanks
VivoSim Labs Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
VIVS|VivoSim Labs Ord Shs|Price:0.419|Chg%:-0.031 - TradingKey
VivoSim Labs, Inc. (VIVS) Stock Price, News, Quote & History - Yahoo! Finance Canada
VivoSim Labs, Inc. (VIVS) stock price, news, quote and history - Yahoo Finance UK
VivoSim Labs (VIVS) Holds Steady Near Support at $0.45 Amid Low VolatilityFactor ETF Flow - dars.gov.et
VIVS Expands into China with First Commercial Sales - GuruFocus
VivoSim secures first commercial sales in China market By Investing.com - Investing.com South Africa
VivoSim secures first commercial sales in China market - Investing.com UK
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services - GlobeNewswire
VivoSim Labs Raises $4 Million in At-the-Market Private Placement to Advance 3D Human Tissue Models for Drug Safety Testing 1 – Minichart - Minichart
VivoSim Labs Announces $4 Million Private Placement Financing - TipRanks
VivoSim Labs Prices $4.0 Million Private Placement and Amends Legacy Armistice Warrants - TradingView
VivoSim prices $0.85 warrants in $4 million private placement - Bitget
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor - Sahm
Why is VivoSim Labs stock falling Thursday? - MSN
VivoSim Labs raises $4M in private placement - Investing.com India
VivoSim Labs prices USD 4 million private placement at USD 0.85 per share - Bitget
VivoSim Labs raises $4M in private placement By Investing.com - Investing.com Nigeria
In today's session, these stocks are experiencing unusual volume. - ChartMill
Why Is VivoSim Labs Stock Falling Thursday? - Benzinga
This stock ticker got caught practicing. It was working last... - Moomoo
VivoSim Labs Announces $4.0 Million Private Placement with Institutional Investor and Warrant Amendment - Quiver Quantitative
VivoSim Announces Pricing of $4.0 Million Private Placement - GlobeNewswire
Why Vivosim Labs Shares Are Rocketing on Wednesday? - Sahm
VivoSim Labs, Inc. announced that it expects to receive $4.000001 million in funding - marketscreener.com
VivoSim Labs (NASDAQ:VIVS) hits $5M milestone; company says 500% revenue jump comes off $131K base - TechStock²
Why is VivoSim Labs stock sliding today? By Investing.com - Investing.com Canada
VivoSim receives $5M milestone payment from Eli Lilly By Investing.com - Investing.com South Africa
VivoSim Labs (VIVS) Forecasts 500% Revenue Growth, Secures $5M M - GuruFocus
Eli Lilly Milestone and Triple-Digit Growth Outlook Put This Microcap in Focus - The Globe and Mail
VivoSim receives $5 million Eli Lilly milestone - grafa.com
VivoSim Labs Rallies on Heavy Volume After Late Annual Report Filing - Quiver Quantitative
VivoSim Gains on Revenue Word - Baystreet.ca
VivoSim Labs stock falls 29% on $4M private placement - scanx.trade
VIVS Stock Whipsaws As Traders Target Volatile Moves - StocksToTrade
VivoSim Receives $5 Million Eli Lilly Milestone Payment, Issues Fiscal 2027 Revenue Growth Outlook - Moomoo
Vivosim Labs, Inc. Provides Revenue Guidance for Fiscal Year 2027 - marketscreener.com
VIVS Predicts Over 500% Revenue Growth by Fiscal Year 2027 - GuruFocus
VIVS Stock Whipsaws As Traders Zero In On Cash Runway - timothysykes.com
VivoSim Labs Announces $5 Million Lilly Milestone Payment and FY2027 Revenue Growth Guidance - Quiver Quantitative
VivoSim Labs Sees FY27 Rev Growing Significantly >VIVS - Moomoo
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027 - Toronto Star
VivoSim: Fiscal Q4 Earnings Snapshot - marketscreener.com
VivoSim Labs, INC. FY 2026: Revenue $0.13M, Net loss $13.84M, EPS $(5.35) — 10-K Summary - TradingView
VivoSim Labs, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
VivoSim Labs, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
VivoSim Labs (VIVS) Tumbles 7.55%: Key Support Levels in FocusCall Dominated - dars.gov.et
VivoSim Labs Faces 7.5% Decline as Stock Tests Key Support at $0.93McClellan Summation - dars.gov.et
Vivosim Labs Inc (VIVS) 財務データ
収益
当期純利益
現金流量
EPS
1.84%
0.86%
大文字化:
|
ボリューム (24 時間):